Evidence map›Paper›PMID 39939517›Full record

ArticleJournal of cancer education : the official journal of the American Association for Cancer Education2025

Implementation of an Educational Intervention for Gastric Cancer Awareness in the General Population in CELAC and Europe: A Strategy Proposed by the LEGACy Consortium.

Juan Antonio Carbonell-Asins, Elena Jiménez-Martí, Sergio Romero, Eduardo García, Ana Miralles-Marco, Beatriz Lopez, Marisol Huerta, Carmelo Caballero, Hugo Boggino, Cinthia Gauna and 18 more

Registry-linked trialAbstract read
In one paragraph

Article in Journal of cancer education : the official journal of the American Association for Cancer Education, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04019808 (Interventional Study at the Primary and Secondary Levels of Prevention for Knowledge Regarding GC Risk Factors in EU and CELAC Populations), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04019808 completednot on this map

Interventional Study at the Primary and Secondary Levels of Prevention for Knowledge Regarding GC Risk Factors in EU and CELAC Populations

TypeobservationalSponsorFundación para la Investigación del Hospital Clínico de ValenciaRan2019 to 2023Enrolled800ConditionsGastric Cancer
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Juan Antonio Carbonell-Asins *Department of Medical Oncology, Hospital Clínico Universitario, Biostatistical Unit, INCLIVA, Biomedical Research Institute, Avenida Menendez Pelayo Nro 4 Accesorio, 46010, Valencia, Spain.
Elena Jiménez-Martí *Department of Medical Oncology Hospital Clínico Universitario, INCLIVA, Biomedical Research Institute, University of Valencia, Avenida Blasco Ibañez 17, 46010, Valencia, Spain.
Sergio RomeroDepartment of Medical Oncology Hospital Clínico Universitario, INCLIVA, Biomedical Research Institute, University of Valencia, Avenida Blasco Ibañez 17, 46010, Valencia, Spain.
Eduardo GarcíaVall d Hebron Institute of Oncology, Biostatistical Unit, Calle Nazaret 155-177 08035, Barcelona, Spain.
Ana Miralles-MarcoDepartment of Medical Oncology Hospital Clínico Universitario, INCLIVA, Biomedical Research Institute, University of Valencia, Avenida Blasco Ibañez 17, 46010, Valencia, Spain.
Beatriz LopezDepartment of Medical Oncology Hospital Clínico Universitario, INCLIVA, Biomedical Research Institute, University of Valencia, Avenida Blasco Ibañez 17, 46010, Valencia, Spain.
Marisol HuertaDepartment of Medical Oncology Hospital Clínico Universitario, INCLIVA, Biomedical Research Institute, University of Valencia, Avenida Blasco Ibañez 17, 46010, Valencia, Spain.
Carmelo CaballeroGenpat. Pathology Department, Guido Spano 1448, Asunción, Paraguay.
Hugo BogginoGenpat. Pathology Department, Guido Spano 1448, Asunción, Paraguay.
Cinthia GaunaOncology Department, Instituto de Previsión Social, Av Santisimo Sacramento y Dr. Manuel Peña, Asunción, Paraguay.
Olga Beatriz Acevedo-FunesCátedra de Biofísica, Universidad Nacional de Asunción, Campus Universitario San Lorenzo, San Lorenzo, Paraguay.
Gabriel Benitez NuñezCátedra de Biofísica, Universidad Nacional de Asunción, Campus Universitario San Lorenzo, San Lorenzo, Paraguay.
Claudia Melina Céspedes-CardozoCátedra de Biofísica, Universidad Nacional de Asunción, Campus Universitario San Lorenzo, San Lorenzo, Paraguay.
Edith A Fernandez-FigueroaNúcleo B de Innovación en Medicina de Precisión, Instituto Nacional de Medicina Genómica, Periferico Sur Número 4809, Colonia Arenal, Tepepán, Alcaldia Tialpan, 14610, Ciudad de México, Mexico.
Nayeli Ortiz-OlveraDepartamento de Gastroenterología, UMAE, Hospital de Especialidades Dr. Bernardo Sepúlveda, Centro Médico Nacional Siglo XXI, IMSS, Avda Cuauhtemoc 330, Doctores, Cuauhtemoc, 06720, Ciudad de México, Mexico.
Erika Ruiz-GarcíaDepartamento de Tumores de Tubo Digestivo, Instituto Nacional de Cancerología, Avda San Fernando 22, Belisario Dominguez, Secc 16, Tialpán, 14080, Ciudad de México, Mexico.
Fátima CarneiroInstitute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Rua Julio Amaral de Carvalho, 45, 4200-135, Porto, Portugal.
Rita BarrosInstitute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Rua Julio Amaral de Carvalho, 45, 4200-135, Porto, Portugal.
Ceu FigueiredoVall d Hebron Institute of Oncology, Biostatistical Unit, Calle Nazaret 155-177 08035, Barcelona, Spain.
Rui M FerreiraInstitute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Rua Julio Amaral de Carvalho, 45, 4200-135, Porto, Portugal.
Tessa Suzanne Groen-van SchootenDepartment of Medical Oncology, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Demi van SantvlietDepartment of Medical Oncology, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Sarah DerksDepartment of Medical Oncology, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Romina LucaOncology Department, Instituto Alexander Flemming, Crammer 1180, C1426, Buenos Aires, Argentina.
Maria AlsinaOncology Department, Vall d Hebron Institute of Oncology, Calle Nazareth 115-117, 08035, Barcelona, Spain.
Arnoldo RiquelmeGastroenterology Department, Pontificia Universidad Católica de Chile, Santiago, Chile.
Andrés Cervantes *Department of Medical Oncology Hospital Clínico Universitario, INCLIVA, Biomedical Research Institute, University of Valencia, Avenida Blasco Ibañez 17, 46010, Valencia, Spain.
Tania Fleitas *Department of Medical Oncology Hospital Clínico Universitario, INCLIVA, Biomedical Research Institute, University of Valencia, Avenida Blasco Ibañez 17, 46010, Valencia, Spain. tfleitas@incliva.es.ORCID 0000-0002-2789-9082

Funding

CONAHCYT 297681Horizon 2020 Framework Programme GA825832
6 · The paper itself

Abstract

Gastric cancer (GC) has a poor prognosis. The LEGACy consortium has been established to enhance GC outcomes though improved primary and secondary prevention strategies. We performed an educational intervention study using an online module to disseminate knowledge about GC risk factors and symptoms to the general population. Participants were recruited through various media channels and were exposed to an online questionnaire to assess their knowledge, before and after the educational intervention. The educational intervention included an informative brochure and a short video providing essential information about GC. Primary outcome was to evaluate the overall knowledge (global score) before and after the intervention. A total of 1034 participants were evaluated before the intervention. Of those, 866 also completed the short-term and 362 the long-term questionnaire after the intervention, respectively. On a scale of 0 to 17, the baseline global score mean was 9.4 (3.2). Results showed an increase in the average global knowledge score by 1.80 (95% CI: 1.63-1.96, p < 0.001) and 1.81 (95% CI: 1.65-1.96, p < 0.001) points after completing the short and long-term questionnaires compared to the baseline respectively for all individual questions (p < 0.05). This interventional study showed significantly improved knowledge in most domains on GC risk factors, signs, and symptoms which could be a useful strategy for promoting cancer prevention. ClinicalTrials.gov Identifier: NCT04019808.

Indexed as

AwarenessHealth EducationHealth Knowledge, Attitudes, PracticePatient Education as TopicStomach NeoplasmsAdultAgedEuropeFemaleFollow-Up StudiesHumansMaleMiddle AgedRisk FactorsSurveys and QuestionnairesGastric cancerGastric cancer risk factorsGastro-esophageal cancerPrevention

Identifiers

PMID39939517
PMCPMC12504374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.